Abstract
Identifying the factors that shape protein expression variability in complex multi-cellular
organisms has primarily focused on promoter architecture and regulation of single-cell
expression in cis. However, this targeted approach has to date been unable to identify major
regulators of cell-to-cell gene expression variability in humans. To address this, we have
combined single-cell protein expression measurements in the human immune system using
flow cytometry with a quantitative genetics analysis. For the majority of proteins whose vari-
ability in expression has a heritable component, we find that genetic variants act in trans,
with notably fewer variants acting in cis. Furthermore, we highlight using Mendelian Ran-
domization that these variability-Quantitative Trait Loci might be driven by the cis regulation
of upstream genes. This indicates that natural selection may balance the impact of gene
regulation in cis with downstream impacts on expression variability in trans.
organisms has primarily focused on promoter architecture and regulation of single-cell
expression in cis. However, this targeted approach has to date been unable to identify major
regulators of cell-to-cell gene expression variability in humans. To address this, we have
combined single-cell protein expression measurements in the human immune system using
flow cytometry with a quantitative genetics analysis. For the majority of proteins whose vari-
ability in expression has a heritable component, we find that genetic variants act in trans,
with notably fewer variants acting in cis. Furthermore, we highlight using Mendelian Ran-
domization that these variability-Quantitative Trait Loci might be driven by the cis regulation
of upstream genes. This indicates that natural selection may balance the impact of gene
regulation in cis with downstream impacts on expression variability in trans.
Original language | English |
---|---|
Article number | e1008686. |
Number of pages | 19 |
Journal | PLoS Genetics |
Volume | 16 |
Issue number | 3 |
Early online date | 13 Mar 2020 |
DOIs | |
Publication status | Published - Mar 2020 |
Bibliographical note
The authors wish to thank Dr Arianne Richard and Dr Luis Barreiro for their critical reading of the manuscript. The authors also wish to extend their gratitude to TwinsUK for sharing data. TwinsUK is funded by the Wellcome Trust, Medical Research Council, European Union, the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London.Data Availability Statement
Genotype data from the Milieu Intérieur cohort are available via managed access in the European Genome-Phenome Archive (EGAD00010001489). TwinsUK genotype data are available by approval via the TwinsUK data access committee (https://twinsuk.ac.uk/). All summary statistics are publicly available via:https://content.cruk.cam.ac.uk/jmlab/VariabilityGenetics/. Processing and analysis code are publicly available via https://github.com/MarioniLab/VariabilityGenetics2019.Funding
MDM was supported by the Wellcome Trust (grant 105045/Z/14/Z). JCM was supported by core funding from the European Molecular Biology Laboratory and from Cancer Research UK (award number 17197). LQM is supported by the French Government’s Investissement d’Avenir Program, Laboratoire d’Excellence “Milieu Intérieur” (Grant ANR-10-LABX-69-01) and the Fondation pour la Recherche Médicale (Equipe FRM DEQ20180339214). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Funders | Funder number |
---|---|
Wellcome Trust | 105045/Z/14/Z |
European Molecular Biology Laboratory | |
Cancer Research UK | 17197 |
French Government’s Investissement d’Avenir Program | ANR-10-LABX-69-01 |
Fondation pour la Recherche Médicale | DEQ20180339214 |